NVIDIA GTC 2026 turns healthcare AI into a pop-culture phenomenon
1. Jensen Huang’s GTC 2026 keynote has redefined health care artificial intelligence as essential infrastructure, moving the technology from the ...
Tag: Pharma
The Scan by 2 Minute Medicine®: Susie Wiles breast cancer diagnosis drives national screening surge, Jensen Huang’s GTC keynote turns healthcare AI into a pop-culture phenomenon, landmark ACSM guidelines simplify resistance training for longevity, and consumer alert issued for high-pressure cosmetic surgery chains
The Scan by 2 Minute Medicine® is a pop-culture medical newsletter and exclusive benefit for 2 Minute Medicine Plus subscribers. ...
Oral infigratinib boosts growth velocity in achondroplasia study
1. Oral infigratinib achieved the highest growth velocity reported to date in a randomized achondroplasia trial, growing 2.10 cm/year faster ...
![2MM: AI Roundup- AI Cancer Test, Smarter Hospitals, Faster Drug Discovery, and Mental Health Tech [May 2nd, 2025]](https://www.2minutemedicine.com/wp-content/uploads/2025/05/Untitled-design-350x250.png)
Artificial intelligence designed drugs Hit 90% Phase I success rate in trials
1. AI-native biotechnology firms are reporting Phase I success rates between 80% and 90%, nearly doubling the historical industry average ...
2MM: AI Roundup- Medtronic’s AI-Robotic Spine Platform, 90% Phase I Success for AI-Designed Drugs, and UCSD’s AI Cancer Risk Predictor [Feb 17th, 2026]
Medtronic Stealth AXiS system integrates AI-robotics for spine care The FDA recently issued a landmark clearance for a surgical platform ...
![CRISPR-mediated gene activation rescues obesity caused by haploinsufficiency [PreClinical]](https://www.2minutemedicine.com/wp-content/uploads/2019/03/CRISPR-350x250.jpg)
Illumina’s billion cell atlas tries to solve artificial intelligence’s data bottleneck in biology
1. Illumina’s Billion Cell Atlas aims to standardize massive CRISPR perturbation data to make biological response patterns more learnable for ...
AstraZeneca moves to own multimodal oncology AI with Modella
1. AstraZeneca is acquiring Modella AI to embed multimodal foundation models into oncology R&D and strengthen biomarker driven trial strategy. ...
NVIDIA and Lilly put $1B behind AI as core drug infrastructure
1. NVIDIA and Eli Lilly plan to invest up to $1B over five years in a joint AI lab to ...
FDA highlights flexible chemistry manufacturing controls expectations for cell and gene therapies
1. New FDA communication introduces a more flexible, risk‑based chemistry, manufacturing, and controls (CMC) framework for cell and gene therapies, ...
Nuzolvence (Zoliflodacin) first oral Gonorrhea treatment shows non-inferior cure rates
1. Nuzolvence (zoliflodacin) is the first single‑dose oral agent for uncomplicated urogenital gonorrhea, showing non‑inferior cure rates to ceftriaxone‑based therapy ...
